eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2013
vol. 17
 
Share:
Share:
abstract:
Review paper

Prognostic value of the Fas/Fas-ligand system in breast cancer

Marek Bębenek
,
Danuta Duś
,
Joanna Koźlak

Wspolczesna Onkol 2013; 17 (2): 120–122
Online publish date: 2013/04/29
View full text Get citation
 
PlumX metrics:
Fas and its ligand (FasL) are known to play a crucial role in the genetically controlled mechanism of cell death, and their deregulation in cancer cells is involved in the immune escape of the tumor. The aim of this review is to analyze the current knowledge on the prognostic value of Fas/FasL in breast cancer patients. Both the results of other authors and our own experiences indicate that the lack of Fas ligand, and particularly Fas, is related to a significantly worse prognosis. It probably results from the resistance of Fas-deficient breast tumors to the mechanisms of apoptosis. On the other hand, some results suggest that the Fas/FasL-dependent mechanisms of tumor spread may be different for various target tissues. The expression of the Fas/Fas-ligand system has potential prognostic ap­plication in view of current knowledge, and consequently should be consider­ed as an additional prognostic factor in breast cancer patients.
keywords:

breast cancer, Fas, Fas ligand, prognosis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.